BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10227678)

  • 1. Drastically abnormal gluco- and galactosylceramide composition does not affect ganglioside metabolism in the brain of mice deficient in galactosylceramide synthase.
    Suzuki K; Vanier MT; Coetzee T; Popko B
    Neurochem Res; 1999 Apr; 24(4):471-4. PubMed ID: 10227678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
    Fewou SN; Büssow H; Schaeren-Wiemers N; Vanier MT; Macklin WB; Gieselmann V; Eckhardt M
    J Neurochem; 2005 Jul; 94(2):469-81. PubMed ID: 15998297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney lipids in galactosylceramide synthase-deficient mice. Absence of galactosylsulfatide and compensatory increase in more polar sulfoglycolipids.
    Tadano-Aritomi K; Hikita T; Fujimoto H; Suzuki K; Motegi K; Ishizuka I
    J Lipid Res; 2000 Aug; 41(8):1237-43. PubMed ID: 10946011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I; Büssow H; Gieselmann V; Eckhardt M
    Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
    Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
    BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice.
    Saadat L; Dupree JL; Kilkus J; Han X; Traka M; Proia RL; Dawson G; Popko B
    Glia; 2010 Mar; 58(4):391-8. PubMed ID: 19705459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of non-hydroxy-galactosylceramides and galactosyldiglycerides by hydroxy-ceramide galactosyltransferase.
    van der Bijl P; Strous GJ; Lopes-Cardozo M; Thomas-Oates J; van Meer G
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):589-97. PubMed ID: 8713090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recycling of glucosylceramide and sphingosine for the biosynthesis of gangliosides and sphingomyelin in rat liver.
    Trinchera M; Ghidoni R; Sonnino S; Tettamanti G
    Biochem J; 1990 Sep; 270(3):815-20. PubMed ID: 2241913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human epidermal glucosylceramides are major precursors of stratum corneum ceramides.
    Hamanaka S; Hara M; Nishio H; Otsuka F; Suzuki A; Uchida Y
    J Invest Dermatol; 2002 Aug; 119(2):416-23. PubMed ID: 12190865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cells.
    van der Bijl P; Lopes-Cardozo M; van Meer G
    J Cell Biol; 1996 Mar; 132(5):813-21. PubMed ID: 8603914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The occurrence of GM4 and GM2 in erythrocytes from inbred strains of mice.
    Hashimoto Y; Otsuka H; Yamakawa T
    J Biochem; 1982 Mar; 91(3):1039-46. PubMed ID: 7076644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large alterations in ganglioside and neutral glycosphingolipid patterns in brains from cases with infantile neuronal ceroid lipofuscinosis/polyunsaturated fatty acid lipidosis.
    Svennerholm L; Fredman P; Jungbjer B; Månsson JE; Rynmark BM; Boström K; Hagberg B; Norén L; Santavuori P
    J Neurochem; 1987 Dec; 49(6):1772-83. PubMed ID: 3681296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene.
    Franken S; Wittke D; Mansson JE; D'Hooge R; De Deyn PP; Lüllmann-Rauch R; Matzner U; Gieselmann V
    Lipids Health Dis; 2006 Aug; 5():21. PubMed ID: 16893448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of pathogenesis in twitcher mouse, an enzymatically authentic model of Krabbe's disease.
    Inui K; Nishimoto J; Taniike M; Midorikawa M; Tsukamoto H; Okada S; Yabuuchi H
    J Neurol Sci; 1990 Dec; 100(1-2):124-30. PubMed ID: 2128519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressed UDP-galactose: ceramide galactosyltransferase and myelin protein mRNA in twitcher mouse brain.
    Taniike M; Marcus JR; Nishigaki T; Fujita N; Popko B; Suzuki K; Suzuki K
    J Neurosci Res; 1998 Feb; 51(4):536-40. PubMed ID: 9514207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental changes in glycolipid synthesizing enzymes in the brain of a myelin-deficient mutant Wistar rat.
    Hof L; Csiza CK
    J Neurochem; 1982 Nov; 39(5):1434-9. PubMed ID: 6214615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability.
    Coetzee T; Fujita N; Dupree J; Shi R; Blight A; Suzuki K; Suzuki K; Popko B
    Cell; 1996 Jul; 86(2):209-19. PubMed ID: 8706126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylceramide synthesis in the developing spinal cord and kidney of the twitcher mouse, an enzymatically authentic model of human Krabbe disease.
    Kodama S; Igisu H; Siegel DA; Suzuki K
    J Neurochem; 1982 Nov; 39(5):1314-8. PubMed ID: 6811701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain myelin of genetically obese mice.
    Sena A; Sarliève LL; Rebel G
    J Neurol Sci; 1985 May; 68(2-3):233-43. PubMed ID: 2989440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cerebroside and sulfatide metabolism in glia cells.
    Jungalwala FB; Koul O; Stoolmiller A; Sapirstein VS
    J Neurochem; 1985 Jul; 45(1):191-8. PubMed ID: 2582089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.